18F-FDG PET/CT volumetric parameter predicts prognosis for neuroblastoma with MYCN gain.

Purpose: The aim of the study was to evaluate the value of 18F-FDG PET/CT metabolic parameters in neuroblastoma (NB) with MYCN gain. Methods: A retrospective analysis was conducted on 87 patients with NB (29 with MYCN gain and 58 with MYCN normal). The region of interest of primary tumors were manua...

Descripción completa

Detalles Bibliográficos
Publicado en:Abdominal Radiology Vol. 50; no. 11; pp. 5614 - 5628
Autores principales: Li, Siqi, Liu, Jun, Wang, Guanyun, Kan, Ying, Wang, Wei, Yang, Jigang
Formato: Journal Article
Publicado: Springer Nature Nov2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188952028&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 188952028
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        2366004X
        JT14
      jtl: Abdominal Radiology
      issn: 2366004X
      maglogo: N
    pubinfo:
      dt: Nov2025
      vid: 50
      iid: 11
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        188952028
        184860457
        10.1007/s00261-025-04973-1
        188952028
      ppf: 5614
      ppct: 14
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: 18F-FDG PET/CT volumetric parameter predicts prognosis for neuroblastoma with MYCN gain.
      aug:
        au:
          Li, Siqi
          Liu, Jun
          Wang, Guanyun
          Kan, Ying
          Wang, Wei
          Yang, Jigang
        affil: https://ror.org/013xs5b60 Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, Beijing, China
      sug:
      ab: Purpose: The aim of the study was to evaluate the value of 18F-FDG PET/CT metabolic parameters in neuroblastoma (NB) with MYCN gain. Methods: A retrospective analysis was conducted on 87 patients with NB (29 with MYCN gain and 58 with MYCN normal). The region of interest of primary tumors were manually delineated using 3D slicer™ software, and 18F-FDG PET/CT metabolic parameters, including SUVmax, SUVpeak, SUVmean, MTV and TLG were extracted. Logistic regression analyses were used to identify the relationship between 18F-FDG PET/CT metabolic parameters and MYCN gain. Cox proportional hazards regression models were used to assess the associations between 18F-FDG PET/CT metabolic parameters and EFS and OS. Survival curves were generated using the Kaplan-Meier method, and differences in survival between groups were compared using the log-rank test. Results: A total of 87 NB patients [median age: 40 (20–56) months; 48 girls and 39 boys] were evaluated. Logistic regression analyses revealed that MTV (>133.3 cm3) was an independent predictor of MYCN gain. During the follow-up period of 22 (2–70) months, 21 patients died and 37 patients experienced disease recurrence or progression. Cox proportional hazards regression analyses showed that MTV, in combination with PHOX2B, was an independent prognostic factor for EFS and OS in NB patients with MYCN-gain. Patients with high MTV exhibited significantly shorter EFS and OS compared to those with low MTV. Conclusion: The volumetric parameter MTV derived from 18F-FDG PET/CT imaging can predict MYCN gain in NB patients and provide valuable prognostic information for patients with MYCN-gain NB.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N